Omniscient Neurotechnology gets US FDA clearance for brain mapping software

Home > Technology
By Merima in Technology
Updated 3 years ago

Sydney-based Omniscient Neurotechnology has received the US FDA's 510(k) clearance for its brain mapping software. Quicktome is a digital brain mapping platform that provides clinicians with a visualisation of a patient's brain networks which are responsible for complex functions such as language, movement and cognition. Featuring intuitive browser interfaces, the...

omniscient-neurotechnology-gets-us-fda-clearance-for-brain-mapping-software